Internal Medicine Alert – June 15, 2010
June 15, 2010
View Issues
-
PPI Use and Fracture Risk
Women who used proton pump inhibitors had a modestly increased risk of spine, forearm or wrist, and total fractures, but not hip fractures. -
Monofilament Testing for Diabetic Peripheral Neuropathy
Despite guideline recommendations to utilize monofilaments to detect diabetic peripheral neuropathy, there is a paucity of published literature to support its accuracy. -
Osteoporosis Treatment After Hip Fracture: Missed Opportunities
After hip fracture due to osteoporosis, only 2% of patients had ideal treatment initiated in the hospital with antiresorptive or bone-forming medications combined with calcium and vitamin D -
Sipuleucel-T Suspension for Intravenous Infusion (Provenge®
The first immunotherapy has been approved by the FDA for the treatment of hormone-resistant prostate cancer. -
Clinical Briefs by Louis Kuritzky, MD
-
ECG Review: RBBB Plus?
The ECG shown above was obtained from a 47-year-old woman with atypical chest pain. Is there more going on in this tracing than just the conduction defect? -
Pharmacology Watch
Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.